STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient

Cancer Gene Therapy, Published online: 22 December 2023; doi:10.1038/s41417-023-00719-7STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient

Source: Cancer Gene Therapy - December 22, 2023 Category: Cancer & Oncology Authors: Shubing Zhang Jinhua Yan Lan He Zhiping Jiang Hao Jiang Source Type: research